glp-1 kidney Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Disease Recommendations for SGLT2i versus GLP-1
Description
If you want to understand the broader treatment path from start to finish, this guide to starting a weight loss journey that lasts is a helpful companion read
Cost-utility of exenatide once weekly compared with insulin glargine in patients with type 2 diabetes in the UK
Connect Dr
The key takeaway is this
Several agents have demonstrated histological and biochemical effects by targeting core pathophysiological pathways
Offering such drugs, including insulin, will attract even more customers
